A Clinical Study of MK-1045 in People with Lupus or Rheumatoid Arthritis (MK-1045-004)

Trial Identifier: 1045-004
Sponsor: MSD
Start Date: February 2026
Primary Completion Date: July 2029
Study Completion Date: July 2029
Condition: Rheumatoid Arthritis; Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary

Trial Locations

Country Location
Australia, Queensland Southport, Queensland, Australia, 4215
Belgium, Limburg Diepenbeek, Limburg, Belgium, 3590
Belgium, Oost-Vlaanderen Gent, Oost-Vlaanderen, Belgium, 9000
China, Beijing Beijing, China, 100005
China, Hubei Wuhan, Hubei, China, 430058
Colombia, Atlantico Barranquilla, Atlantico, Colombia, 080020
Colombia, Cordoba Monteria, Cordoba, Colombia, 230002
Colombia, Valle del Cauca Cali, Valle del Cauca, Colombia, 760032
Georgia, Tbilisi Tbilisi, Georgia, 0112
Italy, Milano Rozzano, Milano, Italy, 20089
Japan, Tokyo Bunkyo, Tokyo, Japan, 113-8655
Japan, Tokyo Shinjyuku, Tokyo, Japan, 160-8582
Moldova, Republic of, Chisinau Chisinau, Moldova, Republic of, 2025
Romania, Bucuresti Bucharest, Bucuresti, Romania, 011658
Romania, Cluj Cluj-Napoca, Cluj, Romania, 400006